Provided By GlobeNewswire
Last update: Feb 2, 2024
Findings support positive proof of mechanism, through successful degradation of methionine, precursor to homocysteine, using dietary disease model in preclinical models and healthy volunteer study
NASDAQ:SYBX (11/26/2025, 1:39:48 PM)
1.73
+0.06 (+3.59%)
Find more stocks in the Stock Screener


